Keybanc analyst Justin Patterson downgrades Meta Platforms (NASDAQ:META) from Overweight to Sector Weight.
SVB Leerink Upgrades scPharmaceuticals to Outperform, Raises Price Target to $11
SVB Leerink analyst Roanna Ruiz upgrades scPharmaceuticals (NASDAQ:SCPH) from Market Perform to Outperform and raises the price target from $6 to $11.